http://hl7.org/fhir/uv/ebm/Citation/179621
type: Citation
node role: treeRoot
id:
  v: 179621
meta:
  version id:
    v: 19
  last updated:
    v: 2025-10-13T12:34:35.118Z
  profile:
    v: http://hl7.org/fhir/uv/ebm/StructureDefinition/journal-article-citation
    l: journal-article-citation
language:
  v: en
text:
  status:
    v: extensions
  div:
    v: Generated Narrative: Citation 179621 version: 19; Last updated: 2025-10-13 12:34:35+0000 Profile: JournalArticleCitation ArtifactPublicationStatus: Active url: Citation 26028518 Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial. identifier: FEvIR Object Identifier/179621, https://pubmed.ncbi.nlm.nih.gov/26028518, <a href="http://terminology.hl7.org/7.0.1/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt #xD;#xA;#xD;#xA;This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: #xD;#xA;#xD;#xA;Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.#xD;#xA;#xD;#xA;This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.15.7 version: 1.0.0-ballot3 title: 26028518 Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial. status: Active date: 2026-01-13 11:03:07+0000 author: Computable Publishing®: MEDLINE-to-FEvIR Converter: publisher: HL7 International / Clinical Decision Support contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss description: This Citation Resource is referenced in an example for the EBMonFHIR Implementa…
contained: Practitioner
  id:
    v: contributor0
  name:
    family:
      v: Fizazi
    given:
      v: Karim
contained: Practitioner
  id:
    v: contributor1
  name:
    family:
      v: Faivre
    given:
      v: Laura
contained: Practitioner
  id:
    v: contributor2
  name:
    family:
      v: Lesaunier
    given:
      v: François
contained: Practitioner
  id:
    v: contributor3
  name:
    family:
      v: Delva
    given:
      v: Remy
contained: Practitioner
  id:
    v: contributor4
  name:
    family:
      v: Gravis
    given:
      v: Gwenaëlle
contained: Practitioner
  id:
    v: contributor5
  name:
    family:
      v: Rolland
    given:
      v: Frédéric
contained: Practitioner
  id:
    v: contributor6
  name:
    family:
      v: Priou
    given:
      v: Frank
contained: Practitioner
  id:
    v: contributor7
  name:
    family:
      v: Ferrero
    given:
      v: Jean-Marc
contained: Practitioner
  id:
    v: contributor8
  name:
    family:
      v: Houede
    given:
      v: Nadine
contained: Practitioner
  id:
    v: contributor9
  name:
    family:
      v: Mourey
    given:
      v: Loïc
contained: Practitioner
  id:
    v: contributor10
  name:
    family:
      v: Theodore
    given:
      v: Christine
contained: Practitioner
  id:
    v: contributor11
  name:
    family:
      v: Krakowski
    given:
      v: Ivan
contained: Practitioner
  id:
    v: contributor12
  name:
    family:
      v: Berdah
    given:
      v: Jean-François
contained: Practitioner
  id:
    v: contributor13
  name:
    family:
      v: Baciuchka
    given:
      v: Marjorie
contained: Practitioner
  id:
    v: contributor14
  name:
    family:
      v: Laguerre
    given:
      v: Brigitte
contained: Practitioner
  id:
    v: contributor15
  name:
    family:
      v: Fléchon
    given:
      v: Aude
contained: Practitioner
  id:
    v: contributor16
  name:
    family:
      v: Ravaud
    given:
      v: Alain
contained: Practitioner
  id:
    v: contributor17
  name:
    family:
      v: Cojean-Zelek
    given:
      v: Isabelle
contained: Practitioner
  id:
    v: contributor18
  name:
    family:
      v: Oudard
    given:
      v: Stéphane
contained: Practitioner
  id:
    v: contributor19
  name:
    family:
      v: Labourey
    given:
      v: Jean-Luc
contained: Practitioner
  id:
    v: contributor20
  name:
    family:
      v: Chinet-Charrot
    given:
      v: Paule
contained: Practitioner
  id:
    v: contributor21
  name:
    family:
      v: Legouffe
    given:
      v: Eric
contained: Practitioner
  id:
    v: contributor22
  name:
    family:
      v: Lagrange
    given:
      v: Jean-Léon
contained: ArtifactAssessment

Practitioner
id:
  v: contributor23
name:
  family:
    v: Linassier
  given:
    v: Claude

Practitioner
id:
  v: contributor24
name:
  family:
    v: Deplanque
  given:
    v: Gaël

Practitioner
id:
  v: contributor25
name:
  family:
    v: Beuzeboc
  given:
    v: Philippe

Practitioner
id:
  v: contributor26
name:
  family:
    v: Davin
  given:
    v: Jean-Louis

Practitioner
id:
  v: contributor27
name:
  family:
    v: Martin
  given:
    v: Anne-Laure

Practitioner
id:
  v: contributor28
name:
  family:
    v: Habibian
  given:
    v: Muriel

Practitioner
id:
  v: contributor29
name:
  family:
    v: Laplanche
  given:
    v: Agnès

Practitioner
id:
  v: contributor30
name:
  family:
    v: Culine
  given:
    v: Stéphane

ArtifactAssessment
id:
  v: meshHeading0
artifact: Reference
  l: #
  reference:
    v: #
  type:
    v: Citation
    l: Citation
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier:
    coding: D000368
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D000368
      display:
        v: Aged
      user selected:
        v: false
  free to share:
    v: true
  component:
    type:
      text:
        v: qualifier
    classifier:
      text:
        v: is not a major topic
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier:
    coding: D000726
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D000726
      display:
        v: Androgen Antagonists
      user selected:
        v: false
  free to share:
    v: true
  component:
    type:
      text:
        v: qualifier
    classifier:
      text:
        v: is not a major topic
  component:
    type:
      text:
        v: qualifier
    classifier:
      coding: Q000627
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier:
    coding: D000971
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D000971
      display:
        v: Antineoplastic Combined Chemotherapy Protocols
      user selected:
        v: false
  free to share:
    v: true
  component:
    type:
      text:
        v: qualifier
    classifier:
      text:
        v: is not a major topic
  component:
    type:
      text:
        v: qualifier
    classifier:
      coding: Q000627
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier:
    coding: D018572
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D018572
      display:
        v: Disease-Free Survival
      user selected:
        v: false
  free to share:
    v: true
  component:
    type:
      text:
        v: qualifier
    classifier:
      text:
        v: is not a major topic
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier:
    coding: http://id.nlm.nih.gov/mesh/D000077143
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D000077143
      display:
        v: Docetaxel
      user selected:
        v: false
  free to share:
    v: true
  component:
    type:
      text:
        v: qualifier
    classifier:
      text:
        v: is not a major topic
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier:
    coding: D004305
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D004305
      display:
        v: Dose-Response Relationship, Drug
      user selected:
        v: false

v: Q000627

v: therapeutic use

v: is Major topic

system:
  v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
  l: Thesaurus.owl
code:
  v: C49488
display:
  v: Yes

v: Q000627

v: therapeutic use

v: is Major topic

system:
  v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
  l: Thesaurus.owl
code:
  v: C49488
display:
  v: Yes

v: true

type:
  text:
    v: qualifier
classifier:
  text:
    v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D004334
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D004334
    display:
      v: Drug Administration Schedule
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D004961
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D004961
    display:
      v: Estramustine
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000008
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000008
      display:
        v: administration & dosage
  component:
    type:
      text:
        v: is Major topic

v: C49487

v: No

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D005500
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D005500
    display:
      v: Follow-Up Studies
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D005602
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D005602
    display:
      v: France
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D006801
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D006801
    display:
      v: Humans
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D053208
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D053208
    display:
      v: Kaplan-Meier Estimate
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D008297
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D008297
    display:
      v: Male
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D020714
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D020714
    display:
      v: Maximum Tolerated Dose
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D008875
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D008875
    display:
      v: Middle Aged
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D009361
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D009361
    display:
      v: Neoplasm Invasiveness
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000473
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000473
      display:
        v: pathology
  component:
    type:
      text:
        v: is Major topic

v: C49487

v: No

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D009364
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D009364
    display:
      v: Neoplasm Recurrence, Local
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000453
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000453
      display:
        v: epidemiology
  component:
    type:
      text:
        v: is Major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000473
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000473
      display:
        v: pathology
  component:
    type:
      text:
        v: is Major topic

v: C49487

v: No

v: C49487

v: No

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D009367
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D009367
    display:
      v: Neoplasm Staging
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D016016
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D016016
    display:
      v: Proportional Hazards Models
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D017430
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D017430
    display:
      v: Prostate-Specific Antigen
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000097
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000097
      display:
        v: blood
  component:
    type:
      text:
        v: is Major topic

v: C49488

v: Yes

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D011471
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D011471
    display:
      v: Prostatic Neoplasms
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000188
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000188
      display:
        v: drug therapy
  component:
    type:
      text:
        v: is Major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000401
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000401
      display:
        v: mortality
  component:
    type:
      text:
        v: is Major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000473
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000473
      display:
        v: pathology
  component:
    type:
      text:
        v: is Major topic

v: C49488

v: Yes

v: C49488

v: Yes

v: C49487

v: No

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D016019
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D016019
    display:
      v: Survival Analysis
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D043823
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D043823
    display:
      v: Taxoids
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier:
    coding: Q000008
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000008
      display:
        v: administration & dosage
  component:
    type:
      text:
        v: is Major topic

v: C49487

v: No

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier:
  coding: D016896
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D016896
    display:
      v: Treatment Outcome
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

url:
  v: http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status
  l: artifact-publication-status
value: CodeableConcept
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-status-type
      l: cited-artifact-status-type
    code:
      v: active
    display:
      v: Active

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/v2-0203
      l: v2-0203
    code:
      v: ACSN
    display:
      v: Accession ID
  text:
    v: FEvIR Object Identifier
system:
  v: https://fevir.net/FOI
  l: FOI
value:
  v: 179621
assigner:
  display:
    v: Computable Publishing LLC

system:
  v: https://pubmed.ncbi.nlm.nih.gov
  l: pubmed.ncbi.nlm.nih.gov
value:
  v: 26028518

system:
  v: urn:ietf:rfc:3986
  l: 3986
value:
  v: urn:oid:2.16.840.1.113883.4.642.40.44.15.7

v: 1.0.0-ballot3

v: 26028518 Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.

v: active

v: 2026-01-13T11:03:07+00:00

name:
  v: Computable Publishing®: MEDLINE-to-FEvIR Converter

v: HL7 International / Clinical Decision Support

name:
  v: HL7 International / Clinical Decision Support
telecom:
  system:
    v: url
  value:
    v: http://www.hl7.org/Special/committees/dss

v: This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.

code:
  system:
    v: http://terminology.hl7.org/CodeSystem/citation-classification-type
    l: citation-classification-type
  code:
    v: fevir-platform-use
  display:
    v: FEvIR Platform Use
value: CodeableConcept
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-artifact-classifier
      l: citation-artifact-classifier
    code:
      v: medline-base
    display:
      v: Medline Base
    user selected:
      v: false

coding:
  system:
    v: http://unstats.un.org/unsd/methods/m49/m49.htm
    l: m49.htm
  code:
    v: 001
  display:
    v: World

v: 2015-09-28

v: 2024-08-05

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-classification-type
      l: citation-classification-type
    code:
      v: citation-source
    display:
      v: Citation Source
classifier:
  text:
    v: MEDLINE

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-classification-type
      l: citation-classification-type
    code:
      v: medline-owner
    display:
      v: MEDLINE Citation Owner
classifier:
  coding:
    system:
      v: https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#owner_value
      l: owner value
    code:
      v: NLM
    display:
      v: National Library of Medicine, Index Section
    user selected:
      v: false

coding:
  system:
    v: http://hl7.org/fhir/citation-status-type
    l: citation-status-type
  code:
    v: medline-medline
  display:
    v: Medline Citation Status of Medline

coding:
  system:
    v: http://hl7.org/fhir/citation-status-type
    l: citation-status-type
  code:
    v: pubmed-publication-status-ppublish
  display:
    v: PubMed PublicationStatus of ppublish

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-received
    display:
      v: PubMed Pubstatus of Received
period:
  end:
    v: 2015-04-15

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-revised
    display:
      v: PubMed Pubstatus of Revised
period:
  end:
    v: 2015-05-06

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-accepted
    display:
      v: PubMed Pubstatus of Accepted
period:
  end:
    v: 2015-05-08

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-entrez
    display:
      v: PubMed Pubstatus of Entrez
period:
  end:
    v: 2015-06-02T06:00:00.000Z

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-pubmed
    display:
      v: PubMed Pubstatus of Pubmed
period:
  end:
    v: 2015-06-02T06:00:00.000Z

activity:
  coding:
    system:
      v: http://hl7.org/fhir/citation-status-type
      l: citation-status-type
    code:
      v: pubmed-pubstatus-medline
    display:
      v: PubMed Pubstatus of Medline
period:
  end:
    v: 2015-09-29T06:00:00.000Z

identifier:
  system:
    v: https://pubmed.ncbi.nlm.nih.gov
    l: pubmed.ncbi.nlm.nih.gov
  value:
    v: 26028518
identifier:
  system:
    v: https://doi.org
    l: doi.org
  value:
    v: 10.1016/S1470-2045(15)00011-X
identifier:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/v2-0203
        l: v2-0203
      code:
        v: ACSN
      display:
        v: Accession ID
    text:
      v: pii
  value:
    v: S1470-2045(15)00011-X
related identifier:
  system:
    v: https://clinicaltrials.gov
    l: clinicaltrials.gov
  value:
    v: NCT00055731
  assigner:
    display:
      v: ClinicalTrials.gov
title:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/title-type
        l: title-type
      code:
        v: primary
      display:
        v: Primary title
  text:
    v: Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
abstract:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-abstract-type
        l: cited-artifact-abstract-type
      code:
        v: primary-human-use
      display:
        v: Primary human use
  text:
    v: **BACKGROUND:** Early risk-stratified chemotherapy is a standard treatment for breast, colorectal, and lung cancers, but not for high-risk localised prostate cancer. Combined docetaxel and estramustine improves survival in patients with castration-resistant prostate cancer. We assessed the effects of combined docetaxel and estramustine on relapse in patients with high-risk localised prostate cancer. **METHODS:** We did this randomised phase 3 trial at 26 hospitals in France. We enrolled patients with treatment-naive prostate cancer and at least one risk factor (ie, stage T3-T4 disease, Gleason score of ≥8, prostate-specific antigen concentration >20 ng/mL, or pathological node-positive). All patients underwent a staging pelvic lymph node dissection. Patients were randomly assigned (1:1) to either androgen deprivation therapy (ADT; goserelin 10·8 mg every 3 months for 3 years) plus four cycles of docetaxel on day 2 at a dose of 70 mg/m(2) and estramustine 10 mg/kg per day on days 1-5, every 3 weeks, or ADT only. The randomisation was done centrally by computer, stratified by risk factor. Local treatment was administered at 3 months. Neither patients nor investigators were masked to treatment allocation. The primary endpoint was relapse-free survival in the intention-to-treat population. Follow-up for other endpoints is ongoing. This study is registered with ClinicalTrials.gov, number NCT00055731. **FINDINGS:** We randomly assigned 207 patients to the ADT plus docetaxel and estramustine group and 206 to the ADT only group. Median follow-up was 8·8 years (IQR 8·1-9·7). 88 (43%) of 207 patients in the ADT plus docetaxel and estramustine group had an event (relapse or death) versus 111 (54%) of 206 in the ADT only group. 8-year relapse-free survival was 62% (95% CI 55-69) in the ADT plus docetaxel and estramustine group versus 50% (44-57) in the ADT only group (adjusted hazard ratio [HR] 0·71, 95% CI 0·54-0·94, p=0·017). Of patients who were treated with radiotherapy and…
  copyright:
    v: Copyright © 2015 Elsevier Ltd. All rights reserved.
relates to:
  type:
    v: comment-in
  classifier:
    coding: D016420
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D016420
      display:
        v: Comment
      user selected:
        v: false
  citation:
    v: Lancet Oncol. 2015 Jul;16(7):741-2. doi: 10.1016/S1470-2045(15)00012-1.
relates to:
  type:
    v: comment-in
  classifier:
    coding: D016420
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D016420
      display:
        v: Comment
      user selected:
        v: false
  citation:
    v: Nat Rev Urol. 2015 Jul;12(7):358. doi: 10.1038/nrurol.2015.146.
relates to:
  type:
    v: comment-in
  classifier:
    coding: D016420
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D016420
      display:
        v: Comment
      user selected:
        v: false
  citation:
    v: Eur Urol. 2015 Dec;68(6):1098-9. doi: 10.1016/j.eururo.2015.08.047.
relates to:
  type:
    v: comment-in
  classifier:
    coding: D016420
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D016420
      display:
        v: Comment
      user selected:
        v: false
  citation:
    v: Nat Rev Clin Oncol. 2015 Dec;12(12):687-8. doi: 10.1038/nrclinonc.2015.192.
publication form:
  published in:
    identifier:
      system:
        v: https://portal.issn.org
        l: portal.issn.org
      value:
        v: 1474-5488
    identifier:
      system:
        v: https://www.issn.org/services/online-services/access-to-the-ltwa/
        l: access-to-the-ltwa
      value:
        v: Lancet Oncol
    identifier:
      system:
        v: https://www.issn.org/understanding-the-issn/assignment-rules/the-issn-l-for-publications-on-multiple-media/
        l: the-issn-l-for-publications-on-multiple-media
      value:
        v: 1470-2045
    identifier:
      system:
        v: https://www.nlm.nih.gov/tsd/cataloging/contructitleabbre.html
        l: contructitleabbre.html
      value:
        v: Lancet Oncol
    identifier:
      system:
        v: https://locatorplus.gov/cgi-bin/Pwebrecon.cgi
        l: https://locatorplus.gov/cgi-bin/Pwebrecon.cgi
      value:
        v: 100957246
    title:
      v: The Lancet. Oncology
    publisher location:
      v: England
  cited medium:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-medium
        l: cited-medium
      code:
        v: internet
      display:
        v: Internet
  volume:
    v: 16
  issue:
    v: 7
  article date:
    v: 2015-07
  page string:
    v: 787-94
publication form:
  cited medium:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-medium
        l: cited-medium
      code:
        v: internet-without-issue
      display:
        v: Internet without issue
  article date:
    v: 2015-05-28
web location:
  classifier:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/artifact-url-classifier
        l: artifact-url-classifier
      code:
        v: abstract
      display:
        v: Abstract
  url:
    v: https://pubmed.ncbi.nlm.nih.gov/26028518/
    l: https://pubmed.ncbi.nlm.nih.gov/26028518/

v: D020492

v: Periodical

system:
  v: https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#issn
  l: issn
code:
  v: Electronic
display:
  v: Electronic

v: Electronic ISSN Type

system:
  v: http://terminology.hl7.org/CodeSystem/v2-0203
  l: v2-0203
code:
  v: XX
display:
  v: Organization identifier

v: ISOAbbreviation

system:
  v: http://terminology.hl7.org/CodeSystem/v2-0203
  l: v2-0203
code:
  v: XX
display:
  v: Organization identifier

v: ISSN Linking

system:
  v: http://terminology.hl7.org/CodeSystem/v2-0203
  l: v2-0203
code:
  v: XX
display:
  v: Organization identifier

v: Medline Title Abbreviation

system:
  v: http://terminology.hl7.org/CodeSystem/v2-0203
  l: v2-0203
code:
  v: XX
display:
  v: Organization identifier

v: NLM Unique ID

classifier:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/artifact-url-classifier
      l: artifact-url-classifier
    code:
      v: doi-based
    display:
      v: DOI Based
url:
  v: https://doi.org/10.1016/S1470-2045(15)00011-X
  l: S1470-2045(15)00011-X

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: publishing-model
    display:
      v: Publishing Model
    user selected:
      v: false
classifier:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-artifact-classifier
      l: citation-artifact-classifier
    code:
      v: Print-Electronic
    display:
      v: Print Electronic
    user selected:
      v: false

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: chemical
    display:
      v: Chemical
    user selected:
      v: false
classifier:
  coding: D000726
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D000726
    display:
      v: Androgen Antagonists
    user selected:
      v: false
classifier:
  coding: D043823
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D043823
    display:
      v: Taxoids
    user selected:
      v: false
classifier:
  coding:
    system:
      v: https://www.cas.org/support/documentation/chemical-substances
      l: chemical-substances
    code:
      v: 15H5577CQD
    user selected:
      v: false
  coding: http://id.nlm.nih.gov/mesh/D000077143
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D000077143
    display:
      v: Docetaxel
    user selected:
      v: false
classifier:
  coding:
    system:
      v: https://www.cas.org/support/documentation/chemical-substances
      l: chemical-substances
    code:
      v: 35LT29625A
    user selected:
      v: false
  coding: D004961
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D004961
    display:
      v: Estramustine
    user selected:
      v: false
classifier:
  coding:
    system:
      v: https://www.cas.org/support/documentation/chemical-substances
      l: chemical-substances
    code:
      v: EC 3.4.21.77
    user selected:
      v: false
  coding: D017430
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D017430
    display:
      v: Prostate-Specific Antigen
    user selected:
      v: false

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
artifact assessment:
  l: meshHeading0
  reference:
    v: #meshHeading0
  type:
    v: ArtifactAssessment
    l: ArtifactAssessment

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: publication-type
    display:
      v: Publication type
classifier:
  coding: D017428
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D017428
    display:
      v: Clinical Trial, Phase III
    user selected:
      v: false
classifier:
  coding: D003160
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D003160
    display:
      v: Comparative Study
    user selected:
      v: false
classifier:
  coding: D016428
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D016428
    display:
      v: Journal Article
    user selected:
      v: false
classifier:
  coding: D016448
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D016448
    display:
      v: Multicenter Study
    user selected:
      v: false
classifier:
  coding: D016449
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D016449
    display:
      v: Randomized Controlled Trial
    user selected:
      v: false
classifier:
  coding: D013485
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D013485
    display:
      v: Research Support, Non-U.S. Gov't
    user selected:
      v: false

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: knowledge-artifact-type
    display:
      v: Knowledge Artifact Type
    user selected:
      v: false
classifier:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-artifact-classifier
      l: citation-artifact-classifier
    code:
      v: D016428
    display:
      v: Journal Article
    user selected:
      v: false
artifact assessment:
  display:
    v: Classifier added by Computable Publishing LLC

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: citation-subset
    display:
      v: Citation subset
    user selected:
      v: false
classifier:
  coding:
    system:
      v: https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#citationsubset
      l: citationsubset
    code:
      v: IM
    display:
      v: IM
    user selected:
      v: false

complete:
  v: true
entry:
  contributor:
    l: contributor0
    reference:
      v: #contributor0
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Fizazi K
  forename initials:
    v: K
  affiliation:
    display:
      v: Institut Gustave Roussy, Villejuif, France. Electronic address: karim.fizazi@gustaveroussy.fr.
entry:
  contributor:
    l: contributor1
    reference:
      v: #contributor1
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Faivre L
  forename initials:
    v: L
  affiliation:
    display:
      v: Institut Gustave Roussy, Villejuif, France.
entry:
  contributor:
    l: contributor2
    reference:
      v: #contributor2
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Lesaunier F
  forename initials:
    v: F
  affiliation:
    display:
      v: Centre François Baclesse, Caen, France.
entry:
  contributor:
    l: contributor3
    reference:
      v: #contributor3
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Delva R
  forename initials:
    v: R
  affiliation:
    display:
      v: Institut de Cancérologie de l'Ouest, Angers, France.
entry:
  contributor:
    l: contributor4
    reference:
      v: #contributor4
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Gravis G
  forename initials:
    v: G
  affiliation:
    display:
      v: Institut Paoli Calmettes, Marseille, France.
entry:
  contributor:
    l: contributor5
    reference:
      v: #contributor5
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Rolland F
  forename initials:
    v: F
  affiliation:
    display:
      v: Institut de Cancérologie de l'Ouest, Nantes, France.
entry:
  contributor:
    l: contributor6
    reference:
      v: #contributor6
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Priou F
  forename initials:
    v: F
  affiliation:
    display:
      v: Centre Hospitalier Départemental, La Roche-sur-Yon, France.
entry:
  contributor:
    l: contributor7
    reference:
      v: #contributor7
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Ferrero JM
  forename initials:
    v: JM
  affiliation:
    display:
      v: Centre Antoine Lacassagne, Nice, France.
entry:
  contributor:
    l: contributor8
    reference:
      v: #contributor8
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Houede N
  forename initials:
    v: N
  affiliation:
    display:
      v: Centre Hospitalier de Nimes, Nimes, France.
entry:
  contributor:
    l: contributor9
    reference:
      v: #contributor9
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Mourey L
  forename initials:
    v: L
  affiliation:
    display:
      v: Institut Claudius Regaud, Toulouse, France.
entry:
  contributor:
    l: contributor10
    reference:
      v: #contributor10
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Theodore C
  forename initials:
    v: C
  affiliation:
    display:
      v: Hôpital Foch, Paris, France.
entry:
  contributor:
    l: contributor11
    reference:
      v: #contributor11
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Krakowski I
  forename initials:
    v: I
  affiliation:
    display:
      v: Centre Alexis Vautrin, Nancy, France.
entry:
  contributor:
    l: contributor12
    reference:
      v: #contributor12
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Berdah JF
  forename initials:
    v: JF
  affiliation:
    display:
      v: Clinique Sainte-Marguerite, Hyères, France.
entry:
  contributor:
    l: contributor13
    reference:
      v: #contributor13

v: Practitioner
l: Practitioner

v: Baciuchka M

v: M

display:
  v: Centre Hospitalier La Timone, Marseille, France.

contributor:
  l: contributor14
  reference:
    v: #contributor14
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Laguerre B
forename initials:
  v: B
affiliation:
  display:
    v: Centre Eugène Marquis, Rennes, France.

contributor:
  l: contributor15
  reference:
    v: #contributor15
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Fléchon A
forename initials:
  v: A
affiliation:
  display:
    v: Centre Léon Bérard, Lyon, France.

contributor:
  l: contributor16
  reference:
    v: #contributor16
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Ravaud A
forename initials:
  v: A
affiliation:
  display:
    v: Hôpital Saint-André, Bordeaux, France.

contributor:
  l: contributor17
  reference:
    v: #contributor17
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Cojean-Zelek I
forename initials:
  v: I
affiliation:
  display:
    v: Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.

contributor:
  l: contributor18
  reference:
    v: #contributor18
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Oudard S
forename initials:
  v: S
affiliation:
  display:
    v: Hôpital Européen Georges Pompidou, Paris, France.

contributor:
  l: contributor19
  reference:
    v: #contributor19
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Labourey JL
forename initials:
  v: JL
affiliation:
  display:
    v: CHU Dupuytren, Limoges, France.

contributor:
  l: contributor20
  reference:
    v: #contributor20
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Chinet-Charrot P
forename initials:
  v: P
affiliation:
  display:
    v: Centre Henri Becquerel, Rouen, France.

contributor:
  l: contributor21
  reference:
    v: #contributor21
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Legouffe E
forename initials:
  v: E
affiliation:
  display:
    v: Centre Médical Oncogard, Nimes, France.

contributor:
  l: contributor22
  reference:
    v: #contributor22
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Lagrange JL
forename initials:
  v: JL
affiliation:
  display:
    v: Hôpital Henri-Mondor, Créteil, France.

contributor:
  l: contributor23
  reference:
    v: #contributor23
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Linassier C
forename initials:
  v: C
affiliation:
  display:
    v: Hôpital Bretonneau, Tours, France.

contributor:
  l: contributor24
  reference:
    v: #contributor24
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Deplanque G
forename initials:
  v: G
affiliation:
  display:
    v: Hôpital Saint-Joseph, Paris, France.

contributor:
  l: contributor25
  reference:
    v: #contributor25
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Beuzeboc P
forename initials:
  v: P
affiliation:
  display:
    v: Institut Curie, Paris, France.

contributor:
  l: contributor26
  reference:
    v: #contributor26
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Davin JL
forename initials:
  v: JL
affiliation:
  display:
    v: Clinique Sainte-Catherine, Avignon, France.

contributor:
  l: contributor27
  reference:
    v: #contributor27
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Martin AL
forename initials:
  v: AL
affiliation:
  display:
    v: Unicancer, Paris, France.

contributor:
  l: contributor28
  reference:
    v: #contributor28
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Habibian M
forename initials:
  v: M
affiliation:
  display:
    v: Unicancer, Paris, France.

contributor:
  l: contributor29
  reference:
    v: #contributor29
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Laplanche A
forename initials:
  v: A
affiliation:
  display:
    v: Institut Gustave Roussy, Villejuif, France.

contributor:
  l: contributor30
  reference:
    v: #contributor30
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Culine S
forename initials:
  v: S
affiliation:
  display:
    v: Hôpital Saint-Louis, Paris, France.